Psychedelic Stock Gainers And Losers From October 17, 2022
Psychedelic Stock Gainers And Losers From October 17, 2022
迷幻股票漲跌者自2022年10月17日起
GAINERS:
贏家:
- Biomind Labs (OTC:BMNDF) shares closed up 38.18% at $1.52
- Numinus Wellness (OTC:NUMIF) shares closed up 5.42% at $0.20
- Compass Pathways (NASDAQ:CMPS) shares closed up 2.43% at $9.69
- Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.40% at $0.93
- Biomind實驗室(場外交易代碼:BMNDF)股價收盤上漲38.18%,至1.52美元
- 努米諾斯健康(場外交易代碼:NUMIF)股價收盤上漲5.42%,至0.2美元。
- 指南針路徑納斯達克:CMPS股價收盤上漲2.43%,至9.69美元
- Seelos治療公司(納斯達克股票代碼:SEEL)股價收盤上漲2.40%,至0.93美元
LOSERS:
失敗者:
- Revive Therapeutics (OTC:RVVTF) shares closed down 10.63% at $0.20
- Allied (OTC:ALID) shares closed down 3.90% at $0.48
- Cybin (AMEX:CYBN) shares closed down 3.60% at $0.55
- ATAI Life Sciences (NASDAQ:ATAI) shares closed down 2.33% at $2.94
- Mind Medicine (NASDAQ:MNMD) shares closed down 0.69% at $2.87
- GH Research (NASDAQ:GHRS) shares closed down 0.00% at $11.74
- 復興治療學(場外交易:RVVTF)股價收盤下跌10.63%,至0.20美元
- 盟軍(場外交易代碼:Alid)股價收盤下跌3.90%,至0.48美元
- Cybin(美國證券交易所代碼:CYBN)股價收盤下跌3.60%,至0.55美元。
- 阿泰生命科學(納斯達克:ATAI)股價收盤下跌2.33%,至2.94美元
- 精神醫學納斯達克股價收盤下跌0.69%,至2.87美元
- GH研究(納斯達克:GHRS)股價收盤下跌0.00%,至11.74美元
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成,並由編輯審閲。